Industry Report “Vein Illuminator Market Research Report - Global Forecast till 2025” provides a clear picture of the Current Market Scenario which includes past and estimated future size with respect to value and volume, technological advancement, macro economical and governing factors in the Digital Commerce Platform market.Dominant players:Major players of global vein illuminator industry are Infrared Imaging Systems Inc., VueTek Scientific LLC, Venoscope LLC, Christie Medical Holdings Inc., Near Infrared Imaging Inc., Sharn Anesthesia, TransLite LLC, AccuVein Inc., Aimvein Ltd. and others.Vein illuminator Market OverviewVein finder or vein illuminator is a device designed to locate and map subcutaneous veins using principles of optical physics.

Vein illuminator employs a variety of techniques such as ultrasound, infrared light and trans-illumination to produce a distinct image of vein structure.Vein illuminator Market growth is expected to register 28.6% CAGR during the forecast period of 2019 to 2025 and held a market value of USD 60.6 Million in 2018.Segments:To generate a bird’s view, the global vein illuminator market is segmented on the basis of technology, and end users.Technology - trans-illumination, infrared illumination, ultrasound, and others.End user - hospitals, blood donation camps, research and academics, others.DriversThe clinical drivers of vein illuminator market are greater patient satisfaction due to reduced pain, trauma, determining correct vascular position in conditions such as obesity, hairy skin, swollen tissue, hypovolemia etc.

The growth of demand factors such as growing numbers of elderly and chronic sick population, blood donation camps, assisted living centers and others are also charging the market.Get Global Vein Illuminator Market Research Report: Information by Technology (Transillumination, Near Infrared Illumination and Ultrasound Technologies), Application (Intravenous Access, Blood Draw and others), End-User (Hospitals, Rehabilitation Facilities, Academic Institutions and others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2025 @ https://www.marketresearchfuture.com/reports/vein-illuminator-market-5735Regional analysis:North America led by the U.S. accounts for the largest market owing to faster adoption of technology, large buying power, developed healthcare infrastructure, presence of major players and others.

Europe led by Germany, U.K. and France is expected to generate the second largest growth.However the market is expected to shift in favor of Asia Pacific region led by China, Japan and India.

China has emerged as a low cost manufacturing base for electronic devices coupled with the development of global supply chains is boosting the market.The Middle East and Africa market is estimated to be skewed in favor of the Gulf nations such as Saudi Arabia, UAE and others.

Africa is expected to generate moderate growth owing to poor economic and political conditions.Related NewsInfluenza Vaccination MarketMucormycosis MarketAbout Market Research Future:MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Market Research Future published a research report on Non-Invasive Prenatal Testing (NIPT) Market Research Report - Global Forecast till 2025.

According to MRFR analysis, the global (NIPT) Market is expected to register a CAGR of 12.8% during the forecast period of 2019 to 2025 and was valued at USD 3,514.765 million in 2018.

As a result of technological advancements, the global maternal mortality rate has reduced approximately less than 70 per 100,000 live births.

The NIPT has benefited resolve issues related DNA deletion and other chromosomal disorders.

The devices segment has been further classified as ultrasound devices, polymerase chain reaction instruments, microarrays, sequencing systems, and others.

Consumables are further segmented into assay kits & reagents, disposables, and others.

Smart Inhalers Market Size, Growth and Trends Analysis By Type (Dry Powder Inhaler and Metered Dose Inhaler), Application (Asthma, Chronic Obstructive Pulmonary Disease and others), Key Players and Region (Americas, Europe, Asia-Pacific and Middle East and Africa), Forecast to 2025Smart Inhalers Market size and share is anticipated to reach USD 4.72 billion at a CAGR of 45% throughout the forecast period (2019-2025).

Increasing population becoming susceptible to indoor air pollutants worldwide and Moreover, improved adherence rate driven by increasing patients preference to use digitalized medical devices for monitoring daily medication doses fosters the growth of the Smart Inhalers Market.Also, increased collaboration deeds between pharmaceutical companies and to promote technological advancements are contributing to market growth.

Increased focus on advancement in treatment methods, R programs, online marketing strategies incorporated by key players in pharmaceutical and biotechnological industries are some of the major trends observed in the market.It is a new-age digital technology designed to empower patients, care contributors, researchers, and physicians related to respiratory diseases through objective and accurate medication monitoring and reminders.

This makes smart inhalers the next big thing in the respiratory care segment.On the other hand, high costs associated with the smart inhalers and COPD & asthma treatments, limited availability of smart inhalers, and misinterpretation of information are some of the major factors obstructing the growth of the Smart Inhalers Market Companies.

Wide range of benefits, including reducing financial costs associated with suboptimal medication adherence to enhanced efficacy of medicines, makes smart inhalers most preferred and popular in the respiratory care segment.leading players include AstraZeneca (UK), Adherium (New Zealand), Cohero Health (US), Gecko Health Innovations, Inc (US), GlaxoSmithKline (UK), Propeller Health (US), and Inspiro Medical (Israel), among others.Highly competitive by nature, the smart inhalers market appears to be fragmented due to the presence of market titans in the market.

Key companies are venturing into new regions and countries with rapid expansion plans.

Market Research Future (MRFR) publishes periodic market research report on Opioids Market Information: By Product (Extended-Release/Long-Acting Opioid, Immediate Release/Short Acting Opioid), by Application (Pain Relief, Anesthesia, Cough Suppression, Deaddiction, Others), by End User, and by Region — Global Forecast till 2023Leading Market PlayersSanofi SA (France), Pfizer Inc. (US), Boehringer Ingelheim GmbH (Germany), Teva Pharmaceutical Industries Ltd (Israel), Allergan Inc. (US), Purdue Pharma L.P. (US), West-Ward Pharmaceuticals Corporation (Jordan), Sun Pharmaceutical Industries Ltd (India), Egalet Corporation (US), Janssen Global Services, LLC (US), Vertice Pharma LLC (UK), Mallinckrodt (Surrey), and others.Opioids Market OverviewThe Opioids Market by types is expected to register a CAGR of 7.12% during the forecast period with a market value of USD 19,554.49 million in 2017.

Opioids are a type of narcotic pain medications that are used to treat moderate to severe pain medications.

According to the National Health Interview Survey 2017, 25.3 million Americans suffer from chronic pain daily and 23.4 million people reported their pain as severe.Segmentation AnalysisThe global opioids market, by product, has been segmented into extended-release/long-acting opioids and immediate-release/short-acting opioids.

The extended-release opioid segment is further segmented into oxycodone, oxymorphone, morphine, hydromorphone, and others.

The extended-release opioid segment accounted for a value of USD 12,750.91 million in 2017.

The immediate-release opioid segment is further segmented into codeine, hydrocodone, fentanyl, morphine, and others.

Epigenetics is the analysis and study of heritable changes in gene function not involving changes in the DNA sequence such as changes in a chromosome, phenotypic affecting gene activity, and expression.The global epigenetics market is valued at USD 800 million in 2016 and is expected to expand at a 12.9 % CAGR during the study period of 2016 to 2023.Market Dynamics:Oncology Segment Is Expected To Be The Largest Driver Of Market GrowthThe growing incidence of cancer is the prime drivers of the market.

cancer was responsible for 8.8 million deaths in 2015, indenting nearly 1 in 6 patients deaths.

Common carcinomas are lung cancer, liver cancer, colorectal cancer, stomach cancer, and breast cancer, recording 1.69 million, 788,000, 774 thousand, 754 thousand, and 571 thousand deaths respectively in the year 2015.

According to the estimates of the Centers for Disease Control and Prevention, almost 1.5 million people are diagnosed with cancer per year in the U.S. alone, resulting in more than five lakh deaths.Technology Development Is Expected To Drive A Faster Market AdoptionThe development of highly sensitive and selective tests, instrumentation and a concurrent rise in computational power is driving a broad adoption.

The advancements such as the development of DNA and RNA modifying enzymes such as acetylases, methyltransferases, reverse transcriptase, ligases, and other protein-modifying enzymes has generated tremendous enthusiasm and concurrent faster market adoption.The growing government support for biotechnology and growing partnership between academia and industry is another driver of growth.

Attractive and critical advantages of technology exemplified by high-throughput molecular analysis of tissues, such as quick, cost-effective, efficient for less labor intensive and requires a lesser number of steps are the operational and economic driving factors of the market.

Stem cells (SC) are a class of undifferentiated biological cells of a multicellular organism that have the ability to produce indefinite cells of the same type, from which certain types of cells (proliferation and replication) can be produced by differentiation in the body through early life and growth.

The stem has the potential to develop into several different cell types, from muscle cells to brain cells.

The government proposed investing 400 million yuan (around USD 56.4 million) to support stem cell research in China.

SegmentationThe Global Stem Cell Banking Market has been segmented based on cell type, bank type, and application.Based on cell type, the market has been divided into umbilical cord stem cells, adult stem cells, and embryonic stem cells.

On the basis of bank type, the global stem cell banking market has been classified into private banks, public banks, and hybrid banks.

In addition, private banks have flexible collection sites and assured, and secured access offers a competitive advantage over public banks.

Market Research Future (MRFR) publishes periodic market research reports Nuclear Imaging Devices Market Research Report - Global Forecast till 2024 on niche and emerging technologies.

The global nuclear imaging devices market is expected to grow significantly over the forecast period.

It is anticipated that the market held a valuation of USD 2490 million in 2018 and is projected to register a CAGR of 5.2% over the forecast period.The increasing prevalence of cardiovascular disorders is one of the key factors driving the nuclear imaging devices market.

As per the report published by the Centers for Disease Control and Prevention (CDC) in 2017, nearly 92.1 million adults were dealing with at least one type of cardiovascular disease.SegmentationThe global Nuclear Imaging Devices Market size is segmented based on technology, application, end user, and region.The global market for nuclear imaging devices, by technology, is segmented into positron emission tomography (PET), single photon emission computed tomography (SPECT), and planar scintigraphy.

The single-photon-emission computed tomography (SPECT) are further classified as hybrid SPECT systems and standalone SPECT systems.Based on application, the market is segmented into oncology, cardiology, neurology, and others.Based on end user, the market is segmented into hospitals, diagnostic imaging centers, and others.The diagnostic imaging centers segment is expected to witness the fastest growth over the forecast period due to rising adoption of nuclear imaging in diagnostic centers.Intended AudienceMedical devices companiesGovernment and private laboratoriesResearch and development (R) companiesResearch laboratoriesMarket research and consulting service providersGlobal Nuclear Imaging Devices Market Research Report: Information by Technology (PET, SPECT (Hybrid SPECT Systems and Standalone SPECT Systems) and Planar Scintigraphy)), Application (Oncology, Cardiology, Neurology and others), End User (Hospitals, Diagnostic Imaging Centers and others) and Region - Global Forecast till 2024.

For more info visit @https://www.marketresearchfuture.com/reports/nuclear-imaging-devices-market-8014Key PlayersSome of the key players in the global nuclear imaging devices market are Philips Healthcare, Digirad Corporation, Neusoft Medical Systems Co., Ltd., Progenics Pharmaceuticals Inc., Cannon Inc., Surgiceye GmbH, CMR Naviscan, Mediso Medical Imaging Systems Ltd., Agfa-Gevaert Group, General Electric Company, DDD-Diagnostic A/S, Spectrum Dynamics Medical, FMI Medical Systems, Inc., Segamicorp, and others.About Market Research Future:MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Market HighlightsThe Global Surgical Retractors Market held a market value of USD 1,103 Million in 2017 and is projected to grow at a CAGR of 7.8% over the forecast period.Increasing number of surgical procedures leading to increase demand of surgical retractors.

Surgical retractors are one of the important surgical instruments which is used to separate the edges of the wound or surgical incision.Due to increasing prevalence of obesity across the globe many of the companies are in the race to introduce better treatment for obesity.

Companies are using a trend of strategic alliance and acquisition to gain the market and minimize the competition in the market.Additionally, the growing research and development expenditure by the government as well as private sector is likely to contribute to the market growth.

As per the data by the Office for National Statistics, in 2016, the gross domestic expenditure on research and development (R) was Euro 33.1 billion (USD 35.2 billion) in the UK.

However, the cost of surgery and surgical products may hamper the market growth during the assessment period.Regional AnalysisOn regional basis, the Americas is anticipated to dominate the global surgical retractors market owing to the growing R budgets by both government as well as commercial pharmaceutical and biotechnological companies and increasing adoption of advanced technologies in the region.Europe is expected to hold the second largest position in the global surgical retractors market owing to the presence of strong academic & research base and availability of funding for research in the European countries.

Asia Pacific has served an opportunity for developing surgical retractors market in this region due to increasing demand for the better treatment and devices and increasing prevalence of disease like diabetes and obesity.The Middle East & Africa has the least share of the global surgical retractors market.

Medical Marijuana Market 2018 Research Report implements an exhaustive study on Market Research Future.

And also cover the other information such as Medical Marijuana Market trends, Prominent players, chapter-wise Description followed by various user perceptions and Forecast till 2023.Industry Synopsis:Global Medical Marijuana Industry is forecasted to expand remarkably at a CAGR of over 35.4% during the forecast period of 2018-2023.

Medical marijuana or medical cannabis is the unprocessed marijuana plant or its extracts that are used to treat the symptoms of various diseases and other medical conditions.Marijuana consists of chemical components cannabinoids, which can be used as medicine to treat the symptoms caused by illness.

Additionally, increasing U.S. Food and Drug Administration (FDA) approvals for drugs containing cannabinoids are contributing to the growth of the market.

For instance, in June 2018, U.S. Food and Drug Administration (FDA) has approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of epilepsy.The stringent regulatory environment for product approval, increasing use of marijuana for recreational use and side effects caused by long-term use of marijuana are likely to hinder market growth during the forecast period.Top Players:The key players profiled by MRFR that are operating in the global medical marijuana market are Canopy Growth, Aurora Cannabis, Inc., Cannabis Sativa, Inc, GW Pharmaceuticals plc, United Cannabis, MGC Pharma, Aphria, Inc., Tilray, Emerald Health Therapeutics [Canada] Inc., GBSciences, Inc., CanniMed Ltd., Medical Marijuana, Inc, Cara Therapeutics, and Greengro Technologies.Segmentation:The global medical marijuana market has been segmented on the basis of application, route of administration and distribution channel.On the basis of application, the market has been classified as Alzheimer’s disease, cancer, mental health conditions, multiple sclerosis, muscle spasms, glaucoma, and human immunodeficiency virus, acquired immunodeficiency syndrome (HIV/AIDS).

Mental health conditions are differentiated into schizophrenia and posttraumatic stress disorder (PTSD).The route of administration segment has been further divided into oral, topical, inhalation and sublingual.

Industry Report “Lymphedema Treatment Market Research Report — Global Forecast till 2025” provides a clear picture of the Current Market Scenario which includes past and estimated future size with respect to value and volume, technological advancement, macro economical and governing factors in the Lymphedema Treatment Market.Lymphedema Treatment Market is estimated to grow with a CAGR of 4.0%.Market SynopsisThe increasing prevalence of cancer is expected to drive the Global lymphedema treatment market by treatment.The strong clinical pipeline is likely to boost the market growth.

Market players like HERANTIS PHARMA PLC, are developing curative treatment of secondary lymphedema — Lymfactin.

Lymfactin is the world’s first and only clinical-stage gene therapy against lymphedema.

The market potential of the drug is estimated to be around USD 650 Million.Market InfluencerIncreased research & development in the market is estimated to influence the commercialization in the market.

The market is projected to witness a shift from symptomatic treatments to targeted treatment during the forecast period of 2018 to 2025.Key Players3A Health Care (Italy)Bio Compression Systems, Inc. (US)Devon Medical Products (US)HERANTIS PHARMA PLC (Finland)Lohmann & Rauscher (Germany)Mego Afek Ltd (US)SIGVARIS (Switzerland)Tactile Systems Technology Inc. (US)Wright Therapy Products (BSN Medical) (Germany)SegmentationBy TypePrimary Lymphedema is caused by the abnormal development of the lymph system.

Symptoms may occur at birth or older age.

Market Research Future published a research report on Cancer Registry Software Market Research Report — Global Forecast till 2024.

Report gives a clear picture of current market scenario which includes past and estimated future market size.The global cancer registry software market is expected to grow significantly over the forecast period.

The market held a market value of USD 56.4 million in 2018 and is projected to grow at a CAGR of 10.7% over the forecast period.Increasing prevalence of cancer, favorable government initiatives, rising pressure to improve the quality of care and reduce healthcare costs, rising adoption of EHRs, and the growing use of cancer patient registry data for post-marketing surveillance are positively affecting market growth.SegmentationBy type, the market has been segmented into integrated software and standalone software.Based on the deployment model, the market has been segmented into cloud-based models and on-premise models.On the basis of the database type, the market has been segmented into commercial databases and public databases.By functionality, the market has been segmented into patient care management, product outcome evaluation, cancer reporting to meet state and federal regulations, medical research & clinical studies.The cancer registry software market, by end-user, has been segmented into hospitals & medical practices, government organizations & research centers, pharmaceutical, biotechnology, and medical device companies, and others.Table of ContentChapter 6.

Global Cancer Registry Software Market, By Type6.1 Introduction6.2 Integrated SoftwareMarket Estimates & Forecast, By Region, 2019–2024Market Estimates & Forecast, By Country, 2019–20246.3 Standalone SoftwareMarket Estimates & Forecast, By Region, 2019–2024Continued…Global Cancer Registry Software Market Research Report By Type, End User (Hospitals, Medical Practices, Government Organizations, Research Centers, Pharmaceutical, Biotechnology, Medical Device Companies and Others) — Forecast till 2024, For more info visithttps://www.marketresearchfuture.com/reports/cancer-registry-software-market-7852Intended Audience· Software companies· Contract research organizations· Academic and research institutes· Government associationsRelated NewsCraniomaxillofacial (CMF) Devices Market Research Report — Global Forecast till 2024Nuclear Imaging Devices Market Research Report — Global Forecast till 2024About Market Research Future:MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.Contact:https://www.marketresearchfuture.com

Epigenetics is the analysis and study of heritable changes in gene function not involving changes in the DNA sequence such as changes in a chromosome, phenotypic affecting gene activity, and expression.

The global epigenetics market is valued at USD 800 million in 2016 and is expected to expand at a 12.9 % CAGR during the study period of 2016 to 2023.

Market Dynamics: Oncology Segment Is Expected To Be The Largest Driver Of Market Growth The growing incidence of cancer is the prime drivers of the market.

Common carcinomas are lung cancer, liver cancer, colorectal cancer, stomach cancer, and breast cancer, recording 1.69 million, 788,000, 774 thousand, 754 thousand, and 571 thousand deaths respectively in the year 2015.

Attractive and critical advantages of technology exemplified by high-throughput molecular analysis of tissues, such as quick, cost-effective, efficient for less labor intensive and requires a lesser number of steps are the operational and economic driving factors of the market.

Other technological developments include automation, advances in PCR technology, strategic and cross-functional nature of the molecular diagnostic technology and others.High Cost Of Installation And Maintenance And Nascent Stage Of Technology May Hamper The Market Growth The prime market constraints include prohibitive costs of molecular diagnostics, the high cost of manufacturing, consolidated nature of the market has put a premium on the price of the epigenetics products, nascent stage of technology and high power of firms relative to buyers.

Insulin Delivery Devices Market Size, Application and Trends Analysis By Type (Insulin Syringes, Pen, Insulin Pumps, Insulin Jet Injectors, Pen Needles), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Sales And Diabetes Clinics/ Centers), End User and Region, Forecast Till 2025The Global Insulin Delivery Devices Market size is estimated to grow at a CAGR of 7.85% and expected to reach USD 21,804 Million by 2025, says Market Research Future (MRFR).

Insulin delivery frameworks help in infusing insulin into the greasy tissue under the skin.

Factors, such as developing diabetic populace, innovative headways in insulin delivery systems, and favoring repayment arrangements, expanding mindfulness among shoppers on the accessibility of a few delivery devices and advancement of human insulin devices are relied upon to positively affect the insulin delivery devices market.

However, the accessibility of oral insulin as an elective medication delivery technique is probably going to hamper the development of the insulin delivery devices market.

Expanding awareness about diabetic consideration is among the drivers for the insulin delivery devices market.Insulin delivery devices, including traditional syringes, without needle injectors, and auto and pen injectors, have been broadly used for the organization of insulin to treat type 1 diabetes issue.

The worldwide market for insulin delivery devices has seen constantly expanding R Following the outlined course, it is anticipated that an expanding commonness of hyperglycemia, developing selection of self-injectable devices, and rising FDA endorsements drive the market development.

Behavioral Health Services Market Research Report - Global Forecast till 2025Behavior health services provide services to patients with mental health disorders, substance abuse disorders, and other mental disorders.

Around 83% people in the US are suffering from behavioral health issues.

According to Japanese study around 298 people were suffering from various behavioral disorders in 2018.

According to MRFR analysis, behavioral health services market overview is expected to register a CAGR of 3.4% during the forecast period of 2019 to 2025 and was valued at USD 146.3 Billion by 2025.SegmentationThe Global Behavioral Health Services Market has been segmented based on services type, disorder type, and end user.The market, based on services type, has been divided into inpatient hospital treatment, outpatient counseling, home-based treatment services, emergency mental health services, and others.

Around 1.3 million Americans are diagnosed with various behavioral disorders every year.

Rising prevalence of anxiety disorder in most commonly seen in US.

The Global Surgical Snare Market size is expected to grow at an approximate CAGR of 4.4% during the forecast period, 2018–2023.

A surgical snare is a wire hoop use to tighten polyps or small tumors for severing, especially in body cavities.

Surgical snares are extensively utilized in endoscopy.

From the past few years, the market has grown with a rapid pace owing to the increasing number of endoscopy procedures, growing geriatric population, and rising healthcare expenditure.According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), about 30 to 40 percent of people in the United States get an H. pylori infection which is the cause of peptic ulcers.

World Health Organization (WHO) estimates that based on a threshold of 4.4 skilled health professionals per 1000 population, the needs-based shortage of health-care workers globally would be about 17.4 million of which almost 2.6 million are doctors and over 9 million are nurses and midwives.SegmentationThe global surgical snare market is segmented based on usability, application, end user, and region.On the basis of usability, the global surgical snare market is segmented into reusable and single use.

By application, the global surgical snare market by application is categorized into laparoscopy, endoscopy, cystoscopy, otoscopy, laryngoscopy, neuroendoscopy, and others.

Global DNA sequencing market is expected to exhibit a strong 17.64% CAGR over the forecast period from 2018 to 2023, according to the latest research report from Market Research Future (MRFR).

The global DNA sequencing market is mainly driven by the growing prevalence of cancer and the growing awareness of the assistance DNA sequencing can provide in diagnosing it, the growing geriatric population and the growing prevalence of neurodegenerative conditions, and the growing awareness about DNA sequencing.

Cancer is a major healthcare concern in modern times and has become a major disease to defeat for leading players in the global healthcare sector.

Early diagnosis of cancer has been shown to be vital in beating the disease, with early diagnosis and screening significantly improving the chances of patients of beating the disease in the long run.

DNA sequencing can be of help in this matter, as DNA sequencing allows patients to learn if they have a predetermined tendency to develop cancer.

The growing burden of cancer on the global healthcare system is likely to be a major driver for the global illumina dna sequencing market The increasing prevalence of neurodegenerative diseases is also likely to be a major driver for the global DNA sequencing market over the forecast period.